COMP <GO>
BEAM vs ADMA // FORWARD P/E MULTIPLE
Beam Therapeutics Inc. (NASDAQ) VS. ADMA Biologics Inc (NASDAQ) • 15-METRIC TALLY: BEAM 2
— ADMA 7
■ METRIC PARITY
LAST: $27.23 (-5.58%) • MKT CAP: $2.98B
forward-pe
—
LAST: $11.41 (-2.89%) • MKT CAP: $2.63B
forward-pe
15.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BEAM VS. ADMA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BEAM | ADMA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 57.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.10% | 32.90% | -65.00 | ADMA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 12.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.09% | 1.06% | -13.15 | ADMA | /fcf-yield <GO> |
| Operating Margin | -60.00% | 37.50% | -97.50 | ADMA | /operating-margins <GO> |
| Net Profit Margin | -57.20% | 28.80% | -86.00 | ADMA | /net-margins <GO> |
| Revenue Growth (YoY) | 120.00% | 19.60% | +100.40 | BEAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.00 | 12.98 | -6.98 | ADMA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | ADMA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.0 | 67.9 | -4.90 | ADMA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 15.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.98B | $2.63B | $347.0M | BEAM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BEAM REV | ADMA REV | BEAM GROSS % | ADMA GROSS % | BEAM FCF | ADMA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $139.7M | $510.2M | — | 57.4% | -$360.0M | $27.8M |
| FY 2024 | $63.5M | $426.5M | — | 51.5% | -$356.2M | $110.4M |
| FY 2023 | $377.7M | $258.2M | — | — | -$149.2M | $8.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BEAM // BETA —
ADMA // BETA —